Comorbid epilepsy and depression—pharmacokinetic and pharmacodynamic drug interactions
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.988716
Abstract: Background: Major depressive disorder may be encountered in 17% of patients with epilepsy and in patients with drug-resistant epilepsy its prevalence may reach 30%. This indicates that patients with epilepsy may require antidepressant treatment. Purpose:… read more here.
Keywords: depression pharmacokinetic; pharmacology; antidepressant drugs; comorbid epilepsy ... See more keywords